| Document |
Document Title |
|
WO/2020/117654A1 |
The invention is directed at esylate and salicylate salts of cis-N-cyclohexyl-N-ethyl-3-(3-chloro-4-cyclohexylphenyl)prop
-2-enylamine and their pharmaceutical composition. The invention is also directed at the use esylate and salicylate...
|
|
WO/2020/116418A1 |
A compound represented by formula (1). (In the formula, R1-R4 and L1-L4 are as defined in the description; Ar represents a moiety of formula (A) or (B) (wherein R11-R18 and R20-R29 are as defined in the description); and Ar is as defined...
|
|
WO/2020/112357A1 |
Provided herein are compounds of Formula (I), including methods of making the same. The disclosed compounds are succinate dehydrogenase inhibitors and can be useful in, e.g., inhibiting or preventing fungal growth.
|
|
WO/2020/113028A1 |
The present disclosure provides, inter alia, a compound having the structure (1). Also provided are compositions containing a pharmaceutically acceptable carrier and one or more compounds according to the present disclosure. Further prov...
|
|
WO/2020/102936A1 |
A method for preparing a covalent organic framework (COF) material and a method for reversible condensation polymerization/termination polymerization. The COF material prepared by the present method shows high crystallinity, high specifi...
|
|
WO/2020/103006A1 |
A process for preparing a primary amine by reacting an alcohol with ammonia in the present of a metal catalyst comprising metal nanoparticles, wherein the metal nano-particles comprises at least one transition metal in elemental form and...
|
|
WO/2020/106098A1 |
The present specification relates to a compound of chemical formula 1 and an organic light-emitting diode comprising same.
|
|
WO/2019/079607A9 |
The present disclosure relates to a method of preventing or treating a blood disorder (e.g., sickle-cell disease) via administering an EHMT2 inhibitor compound disclosed herein or a pharmaceutical composition thereof to subjects in need ...
|
|
WO/2020/102737A1 |
Disclosed herein are compounds and methods for labeling and quantifying analytes using mass spectrometry.
|
|
WO/2020/098937A1 |
The invention relates to a method for producing an amine by reacting an alcohol, aldehyde and/or ketone with hydrogen and nitrogen-containing compound in the presence of a silver and/or ruthenium promoted cobalt catalyst. The nitrogen-co...
|
|
WO/2020/101413A1 |
The present invention relates to a method for preparing and device for preparing formic acid and, more specifically, to a device for preparing formic acid and method for preparing formic acid efficiently by using same, the device compris...
|
|
WO/2020/093949A1 |
The present invention relates to the field of high-carbon chain alkane diamine preparation, and disclosed thereby are a high-carbon chain alkane diamine, a preparation method therefor and an application thereof. The preparation method fo...
|
|
WO/2020/096001A1 |
A compound represented by formula (1) (wherein R1 to R8, R10 to R19, R30 to R46, Ar, L, and *a are as defined in the description) is useful in providing an organic EL element having improved element performance.
|
|
WO/2020/094847A1 |
The present invention relates to indane derivatives of the formula (I) and mixtures thereof, wherein X is selected from groups of the formulae -A-NH2 or -A-(NAr2), wherein A is a chemical bond or phenylene which is unsubstituted or subst...
|
|
WO/2020/097145A1 |
A polymerizable multifunctional antimicrobial monomer includes a quaternary ammonium cation group, wherein the quaternary ammonium cation ion group is bonded to functional groups and anions having structures chosen from the groups; formu...
|
|
WO/2020/087234A1 |
Disclosed is a method for preparing a benzyl amine compound, i.e., synthesizing a benzyl amine compound by means of an oxidation reaction between a methylbenzene/ethylbenzene compound and arylamine by using an ionic iron(III) complex con...
|
|
WO/2020/090989A1 |
In a production method for a fluorinated aromatic secondary or tertiary amine compound having a fluoroaryl moiety in a molecule, the method comprising reacting a fluorinated aromatic primary amine compound with a chlorinated, brominated,...
|
|
WO/2020/087233A1 |
Disclosed is an application of an ionic iron (III) complex as a catalyst in preparation of a benzylamine compound, that is, an ionic iron (III) complex having a molecular formula of [(RNCHCHNR)CH][FeBr4] (R is tert-butyl) and containing ...
|
|
WO/2020/092693A1 |
An improved method for synthesizing a compound according to formula (I) by reaction of a compound of formula (II) with a sulfinamide according to formula (III). The resultant compound is then reduced and hydrolyzed, and optionally alkyla...
|
|
WO/2020/090294A1 |
Disclosed is an ionic compound which has: at least two cation portions and anion portions, respectively, in a molecule; and at least one linking portion which links two among the cation portions and the anion portions, by using a covalen...
|
|
WO/2020/085396A1 |
A cross-coupling reaction method including: preparation of an aromatic compound (1) that has a leaving group; preparation of a compound (2) capable of a cross-coupling reaction, the compound (2) being selected from aromatic amino compoun...
|
|
WO/2020/085174A1 |
A perovskite nano-crystal thin film comprises a plurality of perovskite nano-crystals which are bonded to each other through ligands to thereby be arranged two-dimensionally or three-dimensionally, wherein each of the perovskite nano-cry...
|
|
WO/2020/086816A1 |
The present invention relates to compounds and methods useful for selectively modulating mTORC1 activity.
|
|
WO/2020/087063A1 |
This invention relates to certain compounds or pharmaceutically acceptable salts thereof, and for the use of the compounds to treat cancer. In another aspect, the disclosure relates to a pharmaceutical composition comprising a compound o...
|
|
WO/2020/083327A1 |
Disclosed in the present invention is an organic compound containing a spirobifluorene structure, having a structure as represented by chemical formula (1), wherein Ar1(Ar2)N-(S1)m- and -(S2)n-NAr3(Ar4) are different, and have symmetrica...
|
|
WO/2020/084599A2 |
The present invention relates to ammonium salts of partially fluorinated organic acids, represented by the general formula 1. The present invention relates also to a synthesis method of said salts as well as its use to the production of ...
|
|
WO/2020/079207A1 |
The present invention relates to processes of preparing N- ((1,2,3,4,5,6,7-hexahydro-s-indacen-4-yl)carbamoyl)-1-isopro
pyl-1H- pyrazole-3-sulfonamide and salts thereof. The present invention further relates to pharmaceutical composition...
|
|
WO/2020/079145A1 |
The present invention provides a new, scalable synthetic method for the preparation of non-racemic 1-cyclopropyl alkyl-1-amines, e.g. (S)- 1-cyclopropyl ethyl-1-amine. The method makes use of inexpensive starting materials (such as cyclo...
|
|
WO/2020/081938A1 |
Compounds are provided having the following structure: (I) or a pharmaceutically acceptable salt, tautomer or stereoisomer thereof, wherein G1, R1, R2, L, and n are as defined herein. Use of the compounds as a component of lipid nanopart...
|
|
WO/2020/078413A1 |
The present invention relates to a nitro compound hydrogenation reaction method and hydrogenation reaction apparatus, capable of achieving the long-term production objectives of continuous reaction, regeneration, and activation of nitro ...
|
|
WO/2020/078414A1 |
A fluidization device, a di-trapezoidal component (13), a fluidization device comprising the di-trapezoidal component (13), and an application of the fluidization device in a hydrogenation method for a nitro compound. The fluidization de...
|
|
WO/2020/080799A1 |
The present invention provides a novel compound and an organic light emitting diode using same.
|
|
WO/2020/075964A1 |
The present invention provides a novel compound and an organic light emitting diode using same.
|
|
WO/2020/072324A1 |
The present invention relates to a cationic lipid having one or more biodegradable groups located in a lipidic moiety (e.g., a hydrophobic chain) of the cationic lipid. These cationic lipids may be incorporated into a lipid particle for ...
|
|
WO/2020/063999A1 |
Disclose herein are mono halogen or methyl-substituted 5-HT 2B antagonist compounds, which have been found with increased binding activity to 5-HT 2B receptor due to the substitution of halogen or methyl, and the method of using the comp...
|
|
WO/2020/067365A1 |
According to the present invention, a processing liquid composition for manufacturing a semiconductor is characterized by comprising a quaternary ammonium hydroxide, and a first organic solvent that dissolves the quaternary ammonium hydr...
|
|
WO/2020/069187A1 |
Described herein are drug combinations that show efficacy against non-APL acute myeloid leukemia (AML) with relatively little toxicity. Using differentiation therapies applied in the APL context, lysine demethylase 1 (LSD1) inhibitors ar...
|
|
WO/2020/064917A1 |
Provided is a process for producing an amine via a hydroaminomethylation reaction of a non- aromatic C-C double bond, said process comprising a step of reacting a compound comprising a non-aromatic C-C double bond with an iminium ion in ...
|
|
WO/2020/060970A1 |
The present disclosure generally relates to methods for the recovery of amines from aqueous mixtures. In particular, the disclosure relates to methods for separating amines from amine-containing aqueous mixtures by adjusting the pH of th...
|
|
WO/2020/058160A1 |
The present invention relates to methods for controlling or preventing infestation of cereal plants by the phytopathogenic microorganism Fusarium pseudograminearum, comprising applying to a crop of plants, the locus thereof, or seed ther...
|
|
WO/2020/060271A1 |
The present invention relates to a compound of chemical formula 1, a composition comprising same, and an organic light emitting diode.
|
|
WO/2020/057274A1 |
Provided is a method for preparing a substituted primary amine, using benzonitrile and its derivatives as a raw material, nano porous palladium as a catalyst, and hydrogen gas as a hydrogen source, so as to prepare the substituted primar...
|
|
WO/2020/054472A1 |
The present invention addresses the issue of providing: a novel squarylium compound that has high light-emission efficiency, in particular little reduction in light-emission efficiency in a solid membrane, and is capable of emitting a ne...
|
|
WO/2020/051946A1 |
A cover layer molecular structure, comprising a high molecular structure formed by bonding of a first center structure and a second center structure, wherein the first center structure is one of 9, 9-dimethyl-2-bromofluorene, 2-bromine-9...
|
|
WO/2020/054627A1 |
The present invention addresses the issue of providing: a novel squarylium compound that has high light-emission efficiency, in particular little reduction in light-emission efficiency in a solid membrane, and is capable of emitting a ne...
|
|
WO/2020/052647A1 |
Involved are a class of spiro-heterocyclic compounds which can act as lysine-specific demethylase 1 (LSD1) inhibitors, and the use of same in the preparation of drugs for treating LSD1-related diseases. Specifically involved are a compou...
|
|
WO/2020/052179A1 |
Provided is a preparation process for an amantadine nitrate derivative. The preparation process comprises preparing the amantadine nitrate derivative from substituted or unsubstituted adamantane used as a raw material by means of the fol...
|
|
WO/2020/049072A1 |
The invention relates to a method for producing dialkylamido element compounds. In particular, the invention relates to a method for producing dialkylamido element compounds of the type E(NRR')X, wherein first M[AIH4] is reacted with HNR...
|
|
WO/2020/050342A1 |
One purpose of the present invention is to provide a dicyclohexylamine salt of N,N'-dibenzylbiotin (and, in particular, a high purity dicyclohexylamine salt of N,N'-dibenzylbiotin) and a production method for the dicyclohexylamine salt o...
|
|
WO/2020/050160A1 |
A hydrogenation catalyst for amide compounds which comprises hydroxyapatite and, fixed thereto, platinum and vanadium, characterized in that 15-80% of the surface of the platinum is covered with vanadium. With the catalyst, it is possibl...
|
